RNMBY(RNMBY)
RNMBY
No analyst ratings available
No analyst price targets available for RNMBY
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $14.24B | $19.33B | $25.76B | $33.38B | $42.18B |
| Low | $13.93B | $18.90B | $25.19B | $32.64B | $41.25B |
| High | $14.61B | $19.82B | $26.41B | $34.23B | $43.25B |
| EBITDA Avg | $2.40B | $3.25B | $4.34B | $5.62B | $7.10B |
| Low | $2.35B | $3.18B | $4.24B | $5.50B | $6.95B |
| High | $2.46B | $3.34B | $4.45B | $5.76B | $7.28B |
| EBIT Avg | $1.82B | $2.47B | $3.28B | $4.26B | $5.38B |
| Low | $1.78B | $2.41B | $3.21B | $4.16B | $5.26B |
| High | $1.86B | $2.53B | $3.37B | $4.36B | $5.52B |
| Net Income Avg | $1.18B | $1.73B | $2.40B | $3.10B | $3.90B |
| Low | $1.15B | $1.68B | $2.33B | $3.01B | $3.78B |
| High | $1.22B | $1.79B | $2.48B | $3.20B | $4.03B |
| EPS Avg | $7.72 | $11.32 | $15.67 | $20.25 | $25.45 |
| Low | $7.50 | $11.00 | $15.23 | $19.67 | $24.72 |
| High | $7.98 | $11.70 | $16.19 | $20.92 | $26.29 |
| Analysts (Rev / EPS) | 10 / 1 | 10 / 1 | 4 / 1 | 5 / 1 | 5 / 1 |
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $3.26B | $6.33B |
| Low | $3.20B | $6.22B |
| High | $3.32B | $6.45B |
| EBITDA Avg | $549M | $1.07B |
| Low | $539M | $1.05B |
| High | $558M | $1.09B |
| EBIT Avg | $416M | $808M |
| Low | $408M | $793M |
| High | $423M | $822M |
| Net Income Avg | $333M | $1.09B |
| Low | $326M | $1.06B |
| High | $341M | $1.11B |
| EPS Avg | $1.43 | $4.66 |
| Low | $1.40 | $4.55 |
| High | $1.46 | $4.77 |
| Analysts (Rev / EPS) | 2 / 1 | 1 / 1 |